X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS TORRENT PHARMA DR. DATSONS LABS/
TORRENT PHARMA
 
P/E (TTM) x -10.9 25.9 - View Chart
P/BV x 0.2 6.3 2.6% View Chart
Dividend Yield % 0.0 3.2 -  

Financials

 DR. DATSONS LABS   TORRENT PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
TORRENT PHARMA
Mar-16
DR. DATSONS LABS/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,720 7.3%   
Low Rs311,134 2.7%   
Sales per share (Unadj.) Rs133.0394.5 33.7%  
Earnings per share (Unadj.) Rs0.2101.8 0.1%  
Cash flow per share (Unadj.) Rs6.6116.3 5.7%  
Dividends per share (Unadj.) Rs040.00 0.0%  
Dividend yield (eoy) %02.8 0.0%  
Book value per share (Unadj.) Rs128.8200.3 64.3%  
Shares outstanding (eoy) m31.66169.22 18.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.6 16.3%   
Avg P/E ratio x516.114.0 3,682.0%  
P/CF ratio (eoy) x11.812.3 96.6%  
Price / Book Value ratio x0.67.1 8.5%  
Dividend payout %039.3 0.0%   
Avg Mkt Cap Rs m2,477241,435 1.0%   
No. of employees `000NA10.9 0.0%   
Total wages/salary Rs m568,559 0.7%   
Avg. sales/employee Rs ThNM6,129.6-  
Avg. wages/employee Rs ThNM785.8-  
Avg. net profit/employee Rs ThNM1,581.3-  
INCOME DATA
Net Sales Rs m4,21166,764 6.3%  
Other income Rs m792,156 3.6%   
Total revenues Rs m4,28968,920 6.2%   
Gross profit Rs m56927,204 2.1%  
Depreciation Rs m2042,461 8.3%   
Interest Rs m4301,859 23.1%   
Profit before tax Rs m1325,041 0.1%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-1,403 0.0%   
Tax Rs m66,414 0.1%   
Profit after tax Rs m517,224 0.0%  
Gross profit margin %13.540.7 33.1%  
Effective tax rate %48.025.6 187.5%   
Net profit margin %0.125.8 0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85246,622 14.7%   
Current liabilities Rs m6,71132,843 20.4%   
Net working cap to sales %3.320.6 16.2%  
Current ratio x1.01.4 71.9%  
Inventory Days Days16174 216.6%  
Debtors Days Days31879 403.1%  
Net fixed assets Rs m3,67339,029 9.4%   
Share capital Rs m317846 37.4%   
"Free" reserves Rs m3,76131,400 12.0%   
Net worth Rs m4,07833,890 12.0%   
Long term debt Rs m1,67118,637 9.0%   
Total assets Rs m12,63390,136 14.0%  
Interest coverage x1.014.5 7.1%   
Debt to equity ratio x0.40.5 74.5%  
Sales to assets ratio x0.30.7 45.0%   
Return on assets %3.421.2 16.3%  
Return on equity %0.150.8 0.2%  
Return on capital %7.748.5 15.8%  
Exports to sales %22.943.3 52.8%   
Imports to sales %14.36.9 208.2%   
Exports (fob) Rs m96428,934 3.3%   
Imports (cif) Rs m6024,584 13.1%   
Fx inflow Rs m96429,185 3.3%   
Fx outflow Rs m6076,021 10.1%   
Net fx Rs m35723,165 1.5%   
CASH FLOW
From Operations Rs m1,34527,132 5.0%  
From Investments Rs m-2,256-7,014 32.2%  
From Financial Activity Rs m-1,200-14,352 8.4%  
Net Cashflow Rs m-2,1115,767 -36.6%  

Share Holding

Indian Promoters % 4.5 71.5 6.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.0 -  
FIIs % 1.4 12.6 10.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 8.8 1,069.3%  
Shareholders   20,807 26,511 78.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  CADILA HEALTHCARE  NOVARTIS  PLETHICO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS